| Literature DB >> 30591662 |
Ingrid M L Augustin1,2, Emiel F M Wouters3,4, Sarah Houben-Wilke5, Swetlana Gaffron6, Daisy J A Janssen7, Frits M E Franssen8,9, Martijn A Spruit10,11,12.
Abstract
The degree of lung function is frequently used as referral criterion for pulmonary rehabilitation. The efficacy of pulmonary rehabilitation was assessed in 518 chronic obstructive pulmonary disease (COPD) patients, after clustering based on a comprehensive pre-rehabilitation lung function assessment. Mean improvements in dyspnea, exercise performance, health status, mood status and problematic activities of daily life after pulmonary rehabilitation were mostly comparable between the seven clusters, despite significant differences in the degree of lung function. The current study demonstrates no significant relationship between the seven lung-function-based clusters and response to pulmonary rehabilitation. Therefore, baseline lung function cannot be used to identify those who will respond well to pulmonary rehabilitation, and moreover, cannot be used as a criterion for referral to pulmonary rehabilitation in patients with COPD.Entities:
Keywords: COPD; pulmonary rehabilitation; response
Year: 2018 PMID: 30591662 PMCID: PMC6352188 DOI: 10.3390/jcm8010027
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1Patients before and after a 40-session comprehensive pulmonary rehabilitation program.
Figure 2Seven different clusters of patients with COPD based on differing respiratory physiome. This figure was published in Augustin et al. [11] Legend Figure 2: The seven lung function clusters in chronic obstructive pulmonary disease (COPD) using Viscovery (Viscovery Software GmbH, Vienna, Austria). Viscovery program placed all subjects on a specific position on the map based on their profile of a comprehensive lung function assessment. Subjects with similar lung function are closer together on the map and vice versa. By drawing lines on the map, the Viscovery program could identify seven different clusters of patients with COPD with a significantly different respiratory physiome (95% confidence interval).
Figure 3Changes following pulmonary rehabilitation. Different panels illustrating the absolute change in Medical Research Council (MRC) dyspnoea grade, 6-min walk distance (6MWD), cycle endurance time (constant work-rate test; CWRT), Canadian Occupational Performance Measure, Performance (COPM-P), Canadian Occupational Performance Measure, Satisfaction (COPM-S), Hospital Anxiety and Depression Scale, Anxiety (HADS-A), Hospital Anxiety and Depression Scale, Depression (HADS-D), and St. George’s Respiratory Questionnaire total score (SGRQ-T) for the seven lung function clusters. The other three panels demonstrate the proportion of patients not completing the pulmonary rehabilitation program, the proportion of clinically relevant outcomes (exceeding at least one minimal clinically important difference (MCID) and the proportion of clinically relevant outcomes (exceeding at least two MCID) for each lung function cluster.
Changes following a pulmonary rehabilitation program for the seven lung function clusters.
| Outcomes | Whole Sample | Cluster 1 | Cluster 2 | Cluster 3 | Cluster 4 | Cluster 5 | Cluster 6 | Cluster 7 |
|---|---|---|---|---|---|---|---|---|
| All patients | ||||||||
| Drop out, % patients | 19 | 16 | 33 * | 17 | 11 | 27 | 15 | 18 |
| Number of patients completing pulmonary rehabilitation | ||||||||
| Baseline mMRC dyspnea, grade | 2.4 (1.0) | 2.0 (1.0) ** | 2.6 (1.1) | 2.1 (1.0) ** | 2.0 (1.0) ** | 2.7 (0.9) | 2.8 (0.9) * | 2.9 (1.0) * |
| ΔmMRC dyspnea, grade | −0.3 (1.1) | −0.2 (1.3) | −0.4 (1.1) | −0.2 (1.1) | −0.2 (0.9) | −0.4 (1.0) | −0.5 (1.2) | −0.4 (1.0) |
| • −1 grade, % patients | 39 | 3 | 54 | 30 | 33 | 41 | 47 | 47 |
| • −2 grades, % patients | 16 | 16 | 15 | 16 | 9 | 21 | 25 | 11 |
| Baseline 6MWD | 424 (124) | 466 (118) * | 430 (131) | 445 (115) | 495 (94) * | 413 (100) | 400 (112) | 340 (131) ** |
| Δ6MWD, m | 23 (67) | 28 (73) | 28 (71) | 18 (54) | 26 (60) | 32 (55) | 11 (52) | 19 (94) |
| • ≥30 m, % patients | 44 | 51 | 54 | 40 | 43 | 54 | 37 | 33 |
| • ≥60 m, % patients | 22 | 21 | 28 | 21 | 21 | 23 | 18 | 22 |
| Baseline CWRT, s | 296 (219) | 356 (225) * | 307 (297) | 266 (173) | 353 (221) * | 293 (216) | 247 (136) | 242 (222) |
| ΔCWRT, s | 206 (306) | 288 (308) | 189 (290) | 218 (327) | 254 (316 | 280 (305) | 141 (245) | 57 (265) ** |
| • ≥100 s, % patients | 52 | 67 | 50 | 47 | 61 | 69 * | 49 | 23 ** |
| • ≥200 s, % patients | 36 | 49 | 32 | 32 | 49 | 42 | 36 | 13 ** |
| Baseline COPM-P, points | 3.9 (1.4) | 3.8 (1.4) | 4.1 (1.4) | 4.0 (1.5) | 4.3 (1.3) * | 3.8 (1.0) | 3.7 (1.4) | 3.4 (1.4) ** |
| ΔCOPM-P, points | 2.8 (1.8) | 3.1 (2.0 | 2.5 (2.0) | 2.6 (2.1) | 2.4 (1.8) | 3.0 (1.5) | 3.0 (1.7) | 2.9 (1.6) |
| • ≥2 points, % patients | 68 | 77 | 55 | 62 | 62 | 77 | 72 | 72 |
| • ≥4 points, % patients | 26 | 35 | 26 | 25 | 21 | 30 | 26 | 23 |
| Baseline COPM-S, points | 3.3 (1.7) | 3.3 (1.7) | 4.0 (1.7) * | 3.4 (1.6) | 3.7 (1.8) | 3.2 (1.3) | 2.9 (1.6) | 2.9 (1.6) ** |
| ΔCOPM-S, points | 3.5 (2.2) | 3.7 (2.3) | 2.7 (1.9) ** | 3.3 (2.3) | 3.3 (2.3) | 3.8 (1.9) | 4.0 (1.8) | 3.6 (2.2) |
| • ≥2 points, % patients | 77 | 77 | 66 | 75 | 70 | 86 | 88 | 75 |
| • ≥4 points, % patients | 43 | 46 | 29 | 38 | 44 | 46 | 49 | 49 |
| Baseline HADS-A, points | 7.8 (4.5) | 7.8 (4.2) | 7.1 (4.6) | 7.7 (4.7) | 7.3 (3.5) | 7.6 (4.3) | 8.5 (5.0) | 8.6 (5.0) |
| ΔHADS-A, points | −1.7 (3.7) | −2.0 (3.8) | −0.9 (2.6) | −1.5 (3.4) | −1.1 (3.9) | −1.4 (3.3) | −2.8 (3.7) | −2.2 (4.3) |
| • ≥−1.5 points, % patients | 51 | 48 | 46 | 46 | 48 | 50 | 60 | 56 |
| • ≥−3.0 points or more, % pts | 39 | 41 | 29 | 31 | 34 | 41 | 51 | 48 |
| Baseline HADS-D, points | 7.5 (4.3) | 7.2 (4.3) | 7.6 (4.6) | 7.0 (4.4) | 6.9 (4.0) | 7.9 (3.9) | 7.9 (4.2) | 8.3 (4.8) |
| ΔHADS-D, points | −2.1 (3.7) | −1.4 (3.7) | −2.2 (3.3) | −2.2 (3.6) | −2.0 (4.0) | −2.6 (3.0) | −2.6 (3.2) | −2.2 (4.5) |
| • ≥−1.5 points, % patients | 53 | 41 | 51 | 52 | 52 | 69 | 55 | 54 |
| • ≥−3.0 points, % patients | 39 | 32 | 37 | 36 | 41 | 43 | 47 | 38 |
| Baseline SGRQ total score, points | 61 (17) | 57 (21) | 61 (18) | 58 (17) | 53 (15) ** | 67 (15) * | 67 (15) * | 67 (16) * |
| ΔSGRQ total score, points | −9 (14) | −12.3 (14.6) | −9.5 (14.7) | −6.1 (13.1) | −6.6 (15.6) | −10.9 (10.7) | −11.7 (11.9) | −8.8 (15.1) |
| • ≥−4 points, % patients | 62 | 75 | 54 | 52 | 57 | 71 | 71 | 56 |
| • ≥−8 points or more, % pts | 51 | 61 | 49 | 42 | 49 | 57 | 57 | 46 |
| Outcomes exceeding ≥1 MCID, % | 56 | 59 | 53 | 48 | 52 | 62 | 55 | 45 ** |
| Outcomes exceeding ≥2 MCID, % | 34 | 37 | 31 | 29 | 35 | 36 | 37 | 29 |
Legend of Table 1: The efficacy of pulmonary rehabilitation based on minimal clinically important difference (MCID). Data is presented as mean (SD), unless otherwise stated. Δ: change; mMRC: modified Medical Research Council; 6 MWD: 6-min walk distance; CWRT: constant work-rate test; COPM-P: Canadian Occupational Performance Measure, performance score; COPM-S: Canadian Occupational Performance Measure, satisfaction score; HADS-A: Hospital Anxiety and Depression Scale, anxiety scores; HADS-D: Hospital Anxiety and Depression Scale, depression scores and SGRQ-T: St. George’s Respiratory Questionnaire, total score. * = a significantly higher difference compared to the whole sample (p < 0.01). ** = a significantly lower difference compared to the whole sample (p < 0.01).